170 related articles for article (PubMed ID: 27842672)
21. What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel.
Moldovan PC; Van den Broeck T; Sylvester R; Marconi L; Bellmunt J; van den Bergh RCN; Bolla M; Briers E; Cumberbatch MG; Fossati N; Gross T; Henry AM; Joniau S; van der Kwast TH; Matveev VB; van der Poel HG; De Santis M; Schoots IG; Wiegel T; Yuan CY; Cornford P; Mottet N; Lam TB; Rouvière O
Eur Urol; 2017 Aug; 72(2):250-266. PubMed ID: 28336078
[TBL] [Abstract][Full Text] [Related]
22. Multiparametric prostate MRI: focus on T2-weighted imaging and role in staging of prostate cancer.
Gupta RT; Spilseth B; Patel N; Brown AF; Yu J
Abdom Radiol (NY); 2016 May; 41(5):831-43. PubMed ID: 27193786
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis of Prostate Cancer by Use of MRI-Derived Quantitative Risk Maps: A Feasibility Study.
Chatterjee A; He D; Fan X; Antic T; Jiang Y; Eggener S; Karczmar GS; Oto A
AJR Am J Roentgenol; 2019 Aug; 213(2):W66-W75. PubMed ID: 31039019
[No Abstract] [Full Text] [Related]
24. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
25. Multiparametric magnetic resonance imaging for prostate cancer-a comparative study including radical prostatectomy specimens.
Toner L; Papa N; Perera M; Katelaris N; Weerakoon M; Chin K; Harewood L; Bolton DM; Lawrentschuk N
World J Urol; 2017 Jun; 35(6):935-941. PubMed ID: 27785560
[TBL] [Abstract][Full Text] [Related]
26. Combination of multiparametric MRI and transperineal template-guided mapping biopsy of the prostate to identify candidates for hemi-ablative focal therapy.
Tran M; Thompson J; Böhm M; Pulbrook M; Moses D; Shnier R; Brenner P; Delprado W; Haynes AM; Savdie R; Stricker PD
BJU Int; 2016 Jan; 117(1):48-54. PubMed ID: 25682968
[TBL] [Abstract][Full Text] [Related]
27. Direct comparison of multiparametric magnetic resonance imaging (MRI) results with final histopathology in patients with proven prostate cancer in MRI/ultrasonography-fusion biopsy.
Borkowetz A; Platzek I; Toma M; Renner T; Herout R; Baunacke M; Laniado M; Baretton G; Froehner M; Zastrow S; Wirth M
BJU Int; 2016 Aug; 118(2):213-20. PubMed ID: 26935133
[TBL] [Abstract][Full Text] [Related]
28. An initial negative round of targeted biopsies in men with highly suspicious multiparametric magnetic resonance findings does not exclude clinically significant prostate cancer-Preliminary experience.
Costa DN; Kay FU; Pedrosa I; Kolski L; Lotan Y; Roehrborn CG; Hornberger B; Xi Y; Francis F; Rofsky NM
Urol Oncol; 2017 Apr; 35(4):149.e15-149.e21. PubMed ID: 27939349
[TBL] [Abstract][Full Text] [Related]
29. Comparison of
Zamboglou C; Drendel V; Jilg CA; Rischke HC; Beck TI; Schultze-Seemann W; Krauss T; Mix M; Schiller F; Wetterauer U; Werner M; Langer M; Bock M; Meyer PT; Grosu AL
Theranostics; 2017; 7(1):228-237. PubMed ID: 28042330
[TBL] [Abstract][Full Text] [Related]
30. Pretreatment multiparametric MRI is independently associated with biochemical outcome in men treated with radiation therapy for prostate cancer.
Kauffmann G; Arif F; Patel P; Oto A; Liauw SL
Urol Oncol; 2018 Oct; 36(10):471.e11-471.e18. PubMed ID: 30122344
[TBL] [Abstract][Full Text] [Related]
31. mpMRI preoperative staging in men treated with antiandrogen and androgen deprivation therapy before robotic prostatectomy.
Gold SA; VanderWeele DJ; Harmon S; Bloom JB; Karzai F; Hale GR; Marhamati S; Rayn KN; Mehralivand S; Merino MJ; Gulley JL; Bilusic M; Madan RA; Choyke PL; Turkbey B; Dahut W; Pinto PA
Urol Oncol; 2019 Jun; 37(6):352.e25-352.e30. PubMed ID: 31000430
[TBL] [Abstract][Full Text] [Related]
32. Assessment of free-hand transperineal targeted prostate biopsy using multiparametric magnetic resonance imaging-transrectal ultrasound fusion in Chinese men with prior negative biopsy and elevated prostate-specific antigen.
Lian H; Zhuang J; Wang W; Zhang B; Shi J; Li D; Fu Y; Jiang X; Zhou W; Guo H
BMC Urol; 2017 Jul; 17(1):52. PubMed ID: 28679370
[TBL] [Abstract][Full Text] [Related]
33. Performance of prostate multiparametric MRI for prediction of prostate cancer extra-prostatic extension according to NCCN risk categories: implication for surgical planning.
Falagario UG; Jambor I; Ratnani P; Martini A; Treacy PJ; Wajswol E; Lantz A; Papastefanou G; Weil R; Phillip D; Lewis S; Haines K; Cormio L; Carrieri G; Kyprianou N; Wiklund P; Tewari AK
Minerva Urol Nefrol; 2020 Dec; 72(6):746-754. PubMed ID: 32182231
[TBL] [Abstract][Full Text] [Related]
34.
Kanoun S; Walker P; Vrigneaud JM; Depardon E; Barbier V; Humbert O; Moulin M; Créhange G; Cormier L; Loffroy R; Brunotte F; Cochet A
Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):986-994. PubMed ID: 28333020
[TBL] [Abstract][Full Text] [Related]
35. [Multiparametric MRI and MRI-TRUS fusion biopsy in patients with prior negative prostate biopsy].
Kesch C; Radtke JP; Distler F; Boxler S; Klein T; Hüttenbrink C; Hees K; Roth W; Roethke M; Schlemmer HP; Hohenfellner M; Hadaschik BA
Urologe A; 2016 Aug; 55(8):1071-7. PubMed ID: 27168038
[TBL] [Abstract][Full Text] [Related]
36. Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging Scans.
Alberts AR; Schoots IG; Bokhorst LP; van Leenders GJ; Bangma CH; Roobol MJ
Eur Urol; 2016 Jun; 69(6):1129-34. PubMed ID: 26651990
[TBL] [Abstract][Full Text] [Related]
37. Is suspicious upstaging on multiparametric magnetic resonance imaging useful in improving the reliability of Prostate Cancer Research International Active Surveillance (PRIAS) criteria? Use of the K-CaP registry.
Yoo S; Hong JH; Byun SS; Lee JY; Chung BH; Kim CS
Urol Oncol; 2017 Jul; 35(7):459.e7-459.e13. PubMed ID: 28476529
[TBL] [Abstract][Full Text] [Related]
38. A prospective study investigating the impact of multiparametric MRI in biopsy-naïve patients with clinically suspected prostate cancer: The PROKOMB study.
Baur ADJ; Henkel T; Johannsen M; Speck T; Weißbach L; Hamm B; König F
Contemp Clin Trials; 2017 May; 56():46-51. PubMed ID: 28279782
[TBL] [Abstract][Full Text] [Related]
39. Confirmatory biopsy of men under active surveillance: extended versus saturation versus multiparametric magnetic resonance imaging/transrectal ultrasound fusion prostate biopsy.
Pepe P; Cimino S; Garufi A; Priolo G; Russo GI; Giardina R; Reale G; Pennisi M; Morgia G
Scand J Urol; 2017 Aug; 51(4):260-263. PubMed ID: 28513296
[TBL] [Abstract][Full Text] [Related]
40. Toward Prostate Cancer Contouring Guidelines on Magnetic Resonance Imaging: Dominant Lesion Gross and Clinical Target Volume Coverage Via Accurate Histology Fusion.
Gibson E; Bauman GS; Romagnoli C; Cool DW; Bastian-Jordan M; Kassam Z; Gaed M; Moussa M; Gómez JA; Pautler SE; Chin JL; Crukley C; Haider MA; Fenster A; Ward AD
Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):188-96. PubMed ID: 27375167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
